Veritas Health Nutrition Therapy Extends Survival by 34% in Stage 4 Pancreatic Cancer Patients, New Clinical Trial Shows

Veritas Health Nutrition Therapy Extends Survival by 34% in Stage 4 Pancreatic Cancer Patients, New Clinical Trial Shows

DENVER–( BUSINESS WIRE )–March 12, 2026– Veritas Health, a leader in reversing metabolic disease, today announced the results of a randomized, controlled phase II clinical trial (RCT), providing an early signal that could change how advanced pancreatic cancer is treated. Conducted in partnership with USC Norris Comprehensive Cancer Center, Mayo Clinic, HonorHealth Research Institute, and … Read more

Veritas Health Nutrition Therapy Extends Survival by 34% in Stage 4 Pancreatic Cancer Patients, New Clinical Trial Shows

Veritas Health Nutrition Therapy Extends Survival by 34% in Stage 4 Pancreatic Cancer Patients, New Clinical Trial Shows

The Verta Nutritional Intervention was shown in a randomized, controlled phase II clinical trial to improve survival outcomes in patients with one of the most lethal cancers. Denver, March 12, 2026–( BUSINESS WIRE )– Verta Health, a leader in metabolic disease prevention, today announced the results of a randomized, controlled phase II clinical trial (RCT), … Read more